FAQ — frequently asked questions on cannabis in Switzerland

The most-asked questions on cannabis in Switzerland — short, precise and updated for 2026. Links to the full FAQ landing.

The structured FAQ hub answers the 120 most-searched questions on CBD, THC, law, medicine and pilots. Every answer carries a source and feeds Google rich-results via FAQPage-JSON-LD — with cantonal nuances for legal questions.

Definition and context

The FAQ hub gathers the most common questions regarding the law, pricing, quality, consumption, and membership into short, verifiable answers.

The situation in Switzerland

The most frequently asked questions in Switzerland revolve around three main topics: what is legal, how much it costs, and how to identify quality. All answers provided here comply with current Swiss law — CBD under 1% THC is unregulated, while anything above this threshold is restricted to medical use or official pilot projects.

What this means in practice

Each answer links to an in-depth guide or the canton tracker, ensuring that all information remains fully verifiable rather than just asserted.

Frequently asked questions

How much does CBD cost in Switzerland?

In retail, CHF 5–10 per gram for indoor flowers; under the club model, CHF 1.00–2.50.

Do I need to provide proof to become a member?

You must be of legal age and have a valid Swiss shipping address. Membership itself is free of charge.

How fast is delivery?

Shipped via Swiss Post, delivery usually takes 1–2 business days in discreet packaging.

Background and development

Switzerland has established a unique regulatory trajectory for cannabis. Since 2011, the Federal Narcotics Act (BetmG) has defined legal cannabis by a pragmatic threshold of less than 1% total THC, making low-THC (CBD) products widely accessible. In contrast, high-THC cannabis remains classified as a controlled substance, but the regulatory landscape is shifting. On 1 August 2022, Switzerland legalized medical cannabis by prescription, allowing doctors to prescribe high-THC formulations directly without requiring an exceptional permit from the Federal Office of Public Health (FOPH/BAG). Simultaneously, the Federal Council enabled scientific pilot studies across major cantons, including Zurich, Basel, Bern, Lausanne, and Geneva. Supervised by local health departments and Swissmedic, these trials monitor regulated adult-use sales to gather public health data. This dual system of open CBD access, streamlined medical prescriptions, and localized pilot programs forms the bedrock of modern Swiss cannabis policy.

Distinctions and misconceptions

Navigating Swiss regulations requires clearing up several common misconceptions. Many people confuse the decriminalization of small-scale possession with complete legalization. Under the BetmG, possessing up to 10 grams of high-THC cannabis is not a criminal offense for adults, but it remains illegal and is subject to a CHF 100 fixed penalty, provided there is no consumption involved. Another critical point of confusion concerns driving. While CBD is legal to buy and consume, the Swiss road traffic safety limit for blood THC is exceptionally strict at 1.5 micrograms per liter. Because even legal CBD products can contain trace amounts of THC up to the 1% threshold, consuming them can easily push drivers over this legal limit. Finally, people often mistake the active pilot studies in specific cantons for general national legalization. These trials are highly restricted, geographically bound scientific experiments, not an open recreational market.

Decision guide for Switzerland

For an adult residing in Switzerland, choosing how to navigate the legal cannabis market involves assessing specific criteria. First, verify the THC content of any product; over-the-counter purchases must remain below the 1% THC limit to avoid criminal prosecution. When purchasing legal CBD, look for Swiss-grown organic options that provide clear lab analysis certificates confirming cannabinoid profiles. If you require high-THC cannabis for therapeutic reasons, contact an authorized Swiss doctor to obtain a formal prescription under the revised BetmG framework. Avoid purchasing unregulated products from illicit street sources, as these carry severe legal risks and lack safety guarantees. If you reside in a participating canton such as Zurich or Basel, check your eligibility to register for local pilot studies. Always prioritize clubs or providers that offer transparent raw materials, display laboratory testing, and openly welcome any adult over eighteen without restrictive waiting lists or hidden membership barriers.

What are the legal consequences of being caught with high-THC cannabis in Switzerland?

If an adult is found in possession of up to 10 grams of cannabis containing over 1% THC, it is treated as a minor infraction rather than a criminal offense. Under Swiss law, this results in a CHF 100 fixed penalty and confiscation of the substance, provided no public consumption occurred. Consuming high-THC cannabis in public remains illegal and carries separate fines.

Can I legally drive in Switzerland after consuming CBD products?

Driving after consuming CBD is highly risky. Swiss road safety laws enforce a strict zero-tolerance threshold of 1.5 micrograms of THC per liter of blood. Since Swiss legal CBD products can contain up to 1% THC, regular or heavy consumption can cause trace THC to accumulate in your system, pushing you over the driving limit and leading to license suspension or fines.

Explore this topic further

These guides explain the background and address practical questions in the Swiss context.

Key figures

  • 220’000+ — Swiss adults regularly consume cannabis (BAG · Suchtmonitoring 2024)
  • 36% — of 15–34 year-olds have tried cannabis (EMCDDA · Country Report Switzerland 2024)
  • CHF 582M — estimated Swiss cannabis black-market revenue per year (Uni Genf · Cannabis Market Estimate 2023)
  • 7 — cities with active or approved pilot projects (BAG · Cannabis Pilotversuche 2026)

Current research

  • Cannabis use in Switzerland — Addiction Monitoring 2024 — Sucht Schweiz, BAG · 2024
  • European Drug Report — Cannabis Chapter — EMCDDA, EUDA · 2024
  • WHO Expert Committee on Drug Dependence — Cannabis Review — WHO ECDD, WHO · 2023